BRIDGE Sweden

✨ Time to go official! Here are the four standout pharmaceutical pilot projects in BRIDGE Sweden, chosen for their scientific excellence and innovative potential. ✅ Anna Dimberg, Uppsala universitet, “Antibody Therapy Targeting CD93 for Treatment of Brain Tumors” ✅ Johan Bengzon and Henrik Ahlenius, Lunds universitet, “In Vivo Gene Therapy for Glioblastoma” ✅ Thuy A. Tran, Karolinska Institutet “Advancing Radiotheranostics for Solid Tumors” ✅ Buzzard Pharmaceuticals “Development of an Improved IL-1 Inhibitor for Chronic Autoinflammatory Conditions” 📣“Our pilot projects will set the standard, helping us identify essential offerings and refine our approach,” says Alexandra Patriksson, project manager for BRIDGE Sweden at Testa Center. 🎯 These selected projects will receive dedicated support to fast-track the commercialization of their biological products through the BRIDGE platform, including: SciLifeLab Drug Discovery & Development Platform, pre-GMP lab and Lund Stem Cell Center, and upscaling of production at Testa Center. 💰 The innovation offices at KI, Lund, and Uppsala University will initially assist with business development. BRIDGE Sweden is funded by Swelife through Vinnova. 📸 Anna Dimberg (Photo: Mikael Wallerstedt/Uppsala University), Johan Bengzon & Henrik Ahlenius (Photo: Tove Smeds, Lunds University), Thuy Tran (Photo: Stefan Zimmerman/KI), Maarten de Chateau, Buzzard Pharmaceuticals. 👉 Read the full article here: https://lnkd.in/dDCBHH94

✨ BRIDGE Sweden was presented at the 10-year anniversary celebration of SciLifeLab Drug Discovery & Development platform last week! We’re incredibly grateful for the invaluable role SciLifeLab plays in supporting the development of biological products here in Sweden. Even more inspiring is their openness to collaborative initiatives like BRIDGE Sweden, which aim to strengthen and streamline the journey of bringing innovative therapies to the market 🚀

We're excited to finally have UP.SIGHT from CYTENA set up for the BRIDGE project in the laboratory at SciLifeLab Drug Discovery & Development platform 🎉   This cutting-edge cell dispenser allows us to rapidly and accurately dispense thousands of single colonies in a 384-well format. What does that mean for our work? In short: enhanced capabilities to screen and select high-producing cell lines, which is crucial for supporting our pilot projects!   Having this technology in place is a huge step forward and a key milestone in our journey. With UP.SIGHT on our side, we’re ready to accelerate progress and look forward to achieving some exciting results 🚀 Testa Center Lund Stem Cell Center STUNS Life science Swelife Vinnova Alexandra Patriksson Niklas Berndt Thalén Esmeralda Woestenenk Malin Wiederholm Anisha Khan Elias Uhlin

Four innovative pharmaceutical projects have been selected as pilot projects for the next phase of development in BRIDGE Sweden! 🎉   These exciting projects will receive dedicated support and funding to accelerate the commercialization of their specific biological product through our platform. This includes drug development, cell line development, process development and upscaling of production. We are also proud to share that a total of 19 expressions of interest to be a pilot project were submitted. A big thank you to everyone who participated.   Stay tuned to get to know more about the selected projects soon! Testa Center, SciLifeLab Drug Discovery & Development, Umeå Biotech Incubator, ALIS, Lund Stem Cell Center and Lunds universitet pre-GMP facility, STUNS Life science

Thank you to everyone who visited us at SciLifeLab Uppsala Site Day! 🙌 Last Thursday, we had a fantastic time discussing innovative ideas and making valuable connections. We’re excited to bring back fresh insights and new contacts to strengthen the BRIDGE Sweden project, particularly in the field of cell line development. We look forward to seeing how these new collaborations will shape the future of science and innovation! 💡

We are going to be at SciLifeLab Uppsala Site Day! 👩🔬 BRIDGE Sweden will be part of the SciLifeLab Uppsala Site Day tomorrow October 17th. Join us in the exhibition area in Testa Center’s booth where we’ll be happy to discuss the project and collaboration opportunities. See you there! 🗓️ October 17th  📍 University Main Building, Uppsala See full program here:  https://lnkd.in/dxuhMMnx #SciLifeLab #BRIDGESweden #LifeSciences #Innovation

We are excited to introduce Niklas Berndt Thalén, who has recently joined the BRIDGE Sweden project! 🎉 Can you share a bit about your background? 🧑🔬 “I’ve spent the last few years in academia, focusing on developing cell lines for biological drugs such as antibodies, enzymes, bi-specific antibodies, and AAV viruses for gene therapy.” What’s your role in the BRIDGE Sweden project? 🤝 “I’ll collaborate closely with both SciLifeLab Drug Discovery & Development and Testa Center, as well as other partners of BRIDGE Sweden, to develop cell lines that support pre-clinical research and help move projects forward.” What are you most excited about? 💡 “I’m looking forward to using my skills to drive innovative research and hopefully play a part in getting life-saving medicines to patients.” You can still catch him by booth C13 at Nordic Life Science Days! #NLSDays2024 #DrugDevelopment #CellLineDevelopment #Collaboration

🌟 We’re live! Welcome to our new LinkedIn page! 🌟 We’re excited to officially launch our project page as we participate at the Nordic Life Science Days. It’s an honor to share our vision and plans at such an important event. Follow us here for the latest updates and insights from our project!   What can you expect from our page? 📅 Invitations to seminars 🔬 Insights related to biological product development 📰 News and milestones from the project 🌍 Updates from conferences and events   Visit us at booth C13 at Nordic Life Science Days where Jesper Hedberg, Alexandra Patriksson, Elias Uhlin, Niklas Berndt Thalén, Malin Wiederholm, and Fanny Blom are present, representing Testa Center, Lund Stem Cell Center & pre-GMP Facility at Lunds universitet, the SciLifeLab Drug Discovery & Development platform and STUNS Life science to learn more about BRIDGE Sweden.